NCT00239031View on ClinicalTrials.gov

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

PHASE3CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Denovo Renal Transplantation

Interventions

DRUG

Enteric-Coated Mycophenolate Sodium

Enteric-Coated Mycophenolate Sodium

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00239031 - Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids | Biotech Hunter | Biotech Hunter